mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population
Retrospective data analysis published by ProSciento and mySugr at ATTD in Paris SAN DIEGO, February 15, 2017 – mySugr and ProSciento, Inc., announced today data from a retrospective observational clinical […]
ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research
SAN DIEGO and GOTHENBURG, Sweden, September 14, 2016 /PRNewswire/ – Prosciento, Inc., a full scope clinical R&D services provider focused exclusively on early phase clinical development programs in metabolic diseases, […]
ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH
SAN DIEGO & SHENZHEN, July 28, 2016 /PRNewswire/ – ProSciento, Inc., a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, announced today a strategic master services agreement with […]
ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism
Collaboration Brings Together Leading U.S. Metabolism-Focused CRO and Largest Canadian Diabetes Site Network SAN DIEGO AND TORONTO, June 10, 2016 /PRNewswire/ – ProSciento Inc., a science-driven clinical research organization (CRO) […]
ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions
Companies to conduct a development program to investigate the clinical value and health economics of mySugr’s portfolio of digital health solutions for diabetes management SAN DIEGO AND VIENNA, AUSTRIA, June […]
ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans
SAN DIEGO, June 6, 2016 – ProSciento Inc., a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, will present study results at this week’s American Diabetes Association (ADA) 76th Scientific […]
ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego
SAN DIEGO, April 5, 2016 – ProSciento, clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today its 12th year as a corporate sponsor of the American Diabetes Association’s […]
Congratulations to Hanmi Pharmaceutical Co., Ltd.
ProSciento is proud to support the clinical research and development activities of Hanmi Pharmaceuticals and congratulate Hanmi and Sanofi on their partnership to develop therapeutics addressing diabetes. The licensing agreement […]
ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego
SAN DIEGO, October 29, 2015 – ProSciento, Inc., an early phase clinical research organization (CRO) focused on diabetes and obesity, looks forward to JDRF’s Walk to Cure Diabetes on Saturday, […]
ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research
SAN DIEGO and EMERYVILLE, CA, October 28, 2015 – ProSciento, Inc., a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, and KineMed, Inc., a drug discovery and development company, announced […]